Myc deletion rescues Apc deficiency in the small intestine

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Adenomatous polyposis coli (APC) gene mutations are central to familial adenomatous polyposis (FAP) and sporadic colorectal cancers.
• APC inactivation leads to constitutive activation of the beta-catenin-Tcf4 transcription complex, a key event in colorectal cancer.
• The proto-oncogene c-MYC is a Wnt pathway target, but its specific role following APC loss in the intestine remains unclear.

Purpose of the Study:

• To investigate the role of Myc in the intestine after Apc loss.
• To determine if Myc mediates the phenotypes associated with Apc deletion.
• To elucidate Myc's function in Wnt target gene activation post-Apc loss.

Main Methods:

• Simultaneous deletion of Apc and Myc genes in the adult murine small intestine.
• Phenotypic analysis of intestinal differentiation, migration, proliferation, and apoptosis.
• Gene expression profiling using array analysis to assess Wnt target gene activation.

Main Results:

• Loss of Myc rescued aberrant differentiation, migration, proliferation, and apoptosis phenotypes caused by Apc deletion.
• Rescue occurred despite sustained high levels of nuclear beta-catenin.
• Myc was found to be essential for the activation of most Wnt target genes after Apc loss.

Conclusions:

• Myc acts as a critical mediator in the early stages of intestinal neoplasia following Apc loss.
• These findings establish Myc as a key downstream effector of the Wnt pathway in Apc-deficient colorectal cancer.
• Targeting Myc may offer a therapeutic strategy for colorectal cancers with APC mutations.